Vinogradsky Alice V, Nguyen Stephanie N, Patel Krushang, Regan Matthew, Axsom Kelly M, Lewis Matthew J, Sayer Gabriel, Uriel Nir, Naka Yoshifumi, Goldstone Andrew B, Takeda Koji
Division of Cardiac, Thoracic & Vascular Surgery, Department of Surgery, Columbia University Irving Medical Center, New York, NY.
Heart Transplant Program, NewYork-Presbyterian Hospital, New York, NY.
JTCVS Open. 2024 Apr 23;19:257-274. doi: 10.1016/j.xjon.2024.04.006. eCollection 2024 Jun.
Congenital heart disease is a risk factor for mortality after orthotopic heart transplantation; however, the impact of preoperative circulation type and primary congenital heart disease diagnosis remains poorly delineated.
We retrospectively reviewed patients with adult congenital heart disease aged 16 years or more who underwent orthotopic heart transplantation at our institution between 2008 and 2022. Patients were categorized as having single-ventricle or biventricular circulation. The primary end point was 5-year post-transplant survival.
Sixty-one patients with adult congenital heart disease (single-ventricle: n = 26 [42.6%], biventricular: n = 35 [57.4%]) underwent orthotopic heart transplantation at 33.7 [interquartile range, 19.1-48.7] years. The most common congenital heart disease diagnosis was hypoplastic left heart syndrome (n = 11, 42.3%) in the single-ventricle group and congenitally corrected transposition of the great arteries (n = 7, 20.0%) in the biventricular group. Twenty-four patients previously underwent Fontan palliation. At transplant, patients in the single-ventricle group were younger (18.5 [interquartile range, 17.6-32.3] years vs 45.0 [interquartile range, 33.0-52.2] years, 001) and more likely to have biopsy-proven cirrhosis (46.2% vs 14.3%01) and protein-losing enteropathy (42.3% vs 2.9%001). Patients in the single-ventricle group also had longer bypass times (223.4 ± 65.3 minutes vs 187.4 ± 59.5 minutes03) and longer durations of mechanical ventilatory support (3.5 [interquartile range, 2.0-6.0] days vs 1.0 [interquartile range, 1.0-2.0] days001). Operative mortality was comparable (11.5% vs 8.6%, = 1). Median follow-up was 6.0 [interquartile range, 2.4-10.0] years. Five-year survival was worse in the single-ventricle group (66.0% ± 10.0% vs 91.3% ± 4.8%03), as was freedom from major rejection (58.3% ± 10.2% vs 84.0% ± 6.6%02). In univariable analysis, hypoplastic left heart syndrome and Fontan circulation were risk factors for post-transplant mortality (hypoplastic left heart syndrome: hazard ratio, 5.0001; Fontan: hazard ratio, 3.5, 03).
Adult patients with congenital heart disease undergoing heart transplant with single-ventricle physiology experienced a more complicated post-transplant course, with worse long-term survival and freedom from rejection. Multicenter studies are required to guide orthotopic heart transplantation decision-making in this complex cohort.
先天性心脏病是原位心脏移植后死亡的一个危险因素;然而,术前循环类型和原发性先天性心脏病诊断的影响仍未得到充分阐明。
我们回顾性分析了2008年至2022年期间在我院接受原位心脏移植的16岁及以上成年先天性心脏病患者。患者被分为单心室或双心室循环。主要终点是移植后5年生存率。
61例成年先天性心脏病患者(单心室:n = 26 [42.6%],双心室:n = 35 [57.4%])在33.7 [四分位间距,19.1 - 48.7]岁时接受了原位心脏移植。单心室组最常见的先天性心脏病诊断是左心发育不全综合征(n = 11,42.3%),双心室组是大动脉转位矫正型(n = 7,20.0%)。24例患者先前接受过Fontan姑息手术。移植时,单心室组患者更年轻(18.5 [四分位间距,17.6 - 32.3]岁对45.0 [四分位间距,33.0 - 52.2]岁,P = 0.001),更有可能有活检证实的肝硬化(46.2%对14.3%,P = 0.01)和蛋白丢失性肠病(42.3%对2.9%,P = 0.001)。单心室组患者的体外循环时间也更长(223.4 ± 65.3分钟对187.4 ± 59.5分钟,P = 0.03),机械通气支持时间更长(3.5 [四分位间距,2.0 - 6.0]天对1.0 [四分位间距,1.0 - 2.0]天,P = 0.001)。手术死亡率相当(11.5%对8.6%,P = 1)。中位随访时间为6.0 [四分位间距,2.4 - 10.0]年。单心室组的5年生存率更差(66.0% ± 10.0%对91.3% ± 4.8%,P = 0.03),无严重排斥反应的比例也更低(58.3% ± 10.2%对84.0% ± 6.6%,P = 0.02)。在单因素分析中,左心发育不全综合征和Fontan循环是移植后死亡的危险因素(左心发育不全综合征:风险比,5.00,P = 0.001;Fontan:风险比,3.5,P = 0.03)。
患有单心室生理状态的先天性心脏病成年患者在心脏移植后经历了更复杂的病程,长期生存率和无排斥反应情况更差。需要多中心研究来指导这一复杂群体的原位心脏移植决策。